Aug 28, 2024 / 01:00AM GMT
Karen Borg - Somnomed Ltd - Joint Co-Chief Executive Officer, Executive Director
welcome to SomnoMed's Full Year 2024 Earnings Call. My name is Karen Borg, Co-CEO of SomnoMed, and I'm joined by Amrita Blickstead, my Co-CEO. We're excited to be presenting the highlights of our financial and operational performance for the year ended June 30, 2024, before opening the call to your questions. I'll move across to FY24 and provide a snapshot on slide 4.
FY24 was a reset year for SomnoMed as we focused on building the foundations for sustainable and profitable long-term growth. We delivered on our guidance with revenue growth of 9.6% year-over-year to $91.7 million and an EBITDA of $0.6 million. It was a year to get the foundations right. A reminder that when Amrita and I came into the business, there were key immediate operational and financial issues that we now feel comfortable saying, have been taken care of or on track to be, and we can look ahead with confidence that we will continue to deliver against stated targets.
We achieved these results by primarily driving operational focus,
Full Year 2024 Somnomed Ltd Earnings Call Transcript
Aug 28, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers